Article info

Download PDFPDF
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY

Authors

Citation

Wasemann C, Ertan AK, Schmidt W, et al
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY
Online issue publication 
September 01, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.